This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Everist Genomics, Inc.. Active years: 2019-2020.
Company Filing History:
Years Active: 2019-2020
Title: Thomas Stephen Everist, III: Innovator in Cardiovascular Diagnostics
Introduction
Thomas Stephen Everist, III is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of medical diagnostics, particularly in assessing cardiovascular health. With a total of 2 patents, his work focuses on innovative methods that enhance the understanding and evaluation of vascular conditions.
Latest Patents
Everist's latest patents include a "System and method for using flow-mediated dilation to provide an adjusted vascular age as an indicator of risk of cardiovascular disease." This diagnostic tool modifies vascular age scoring systems using flow-mediated dilation (FMD) data. The resulting FMD-adjusted vascular age calculator can be utilized to diagnose an individual's potential for developing cardiovascular disease. Another significant patent is the "System and method of assessing endothelial function." This medical diagnostic system adjusts a reactive hyperemia indicator, measured in response to a stimulus, based on anthropomorphic and demographic variables. The adjusted reactive hyperemia indicator offers a more accurate reflection of endothelial function, which can be communicated effectively to clinicians.
Career Highlights
Everist is associated with Everist Genomics, Inc., where he applies his expertise in genomics and diagnostics. His work is pivotal in advancing the understanding of cardiovascular health and improving diagnostic accuracy.
Collaborations
One of his notable coworkers is Peter F. Lenehan, with whom he collaborates on various projects aimed at enhancing medical diagnostics.
Conclusion
Thomas Stephen Everist, III is a distinguished inventor whose work in cardiovascular diagnostics is making a significant impact in the medical field. His innovative patents reflect his commitment to improving health outcomes through advanced diagnostic tools.